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Hypertensive disorders of pregnancy are prevalent com-plications and include preexisting chronic hypertension, 
gestational hypertension and preeclampsia, and preeclampsia 
superimposed on chronic hypertension.1 Among these con-
ditions, preeclampsia associates with the most significant 
immediate risks to offspring and mother,1,2 increases women’s 
long-term risk of end-stage renal disease,3 and cardiovascular 
morbidity and mortality.4–8 Preeclampsia is conceptualized into 
2 primary stages: the first being altered placental perfusion as a 
result of abnormal early trophoblast growth and differentiation, 
poor placentation, or other pathologies and the second involv-
ing maternal responses to placental factors excreted because 
of a dysfunctional placenta.9–17 Further, the pathophysiol-
ogy of preterm and late-onset preeclampsia may differ with 
poor placentation being more important for preterm than term 
preeclampsia.18
Preexisting cardiovascular risk factors may identify 
women at risk for de novo hypertensive disorders of preg-
nancy, where pregnancy acts as a metabolic and vascular stress 
test for women with underlying acquired or genetic predispo-
sitions.19 Gestational hypertension and preeclampsia and term 
and preterm preeclampsia may have important etiologic dif-
ferences, but no study to date has compared the preconception 
risk factor differences between these outcomes. We, therefore, 
evaluated the extent of differences and similarities in the pre-
gravid cardiovascular risk factors associated with gestational 
hypertension, preeclampsia, and preterm preeclampsia using a 
prospective study design linking regional health surveys with 
subsequent pregnancies identified in the Norwegian Medical 
Birth Registry.
We are aware of only 2 earlier studies, of substantially 
smaller sample sizes, that evaluated preconception risk factors 
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for their ability to predict preeclampsia.20,21 As these studies 
had discrepant findings, perhaps owing to the smaller sample 
sizes, the current analyses provide a more robust evaluation 
of preconception risk factors. Also, the current study provides 
novel preconception risk factor information regarding physi-
cal activity and binge drinking and is unique in the literature 
for its evaluation of preconception differences and similarities 
in risk factors for gestational hypertension and preeclampsia.
Methods
Participants in Cohort Norway (CONOR) health surveys (1994–2003) 
were linked, using a national identification number, to the Medical 
Birth Registry of Norway for births subsequent to CONOR participa-
tion (through to December 31, 2012). The Materials and Methods 
in the online-only Data Supplement provides additional details and 
the study design figure. The reproductive-aged women from CONOR 
health surveys22 came from 3 regions (24.2% from Oslo, 49.9% from 
Nord-Trøndelag, and 21.3% from Troms). An earlier study evaluated 
pregravid risk factors in 3494 women in Nord-Trøndelag: a subset 
of the current analyses.21 The majority of CONOR participants were 
ethnic Norwegians, but only 61.9% of women of reproductive age in 
Oslo surveys were born in Norway, given an immigrant survey com-
ponent, in contrast to 97.5% in Nord-Trøndelag and 95.0% in Troms.
Record linkages identified 17 320 births with a mother that par-
ticipated in CONOR before delivery (Figure S1 in the online-only 
Data Supplement). Exclusions included preexisting hypertension, 
nonviable births, mother pregnant during or delivered <1 year before 
CONOR participation, and multiple birth pregnancies, resulting in 
13 217 singleton births for analyses (representing 8321 women; 1.59 
births/woman).
CONOR Assessments
Assessments included height and weight, past-year leisure-time light 
and vigorous physical activity,23 alcohol consumption frequency and 
binge drinking,24 blood pressure, nonfasting lipids,22 and a family his-
tory of diabetes mellitus, stroke, or myocardial infarction before 60 
years of age in first-degree relatives. Analyses used the average of the 
last 2 of 3 systolic and diastolic blood pressure readings taken by an 
automatic device (DINAMAP, Criticon, Tampa, FL). Binge drinking 
was defined as ≥5 drinks/d at least once in the past year. Those who 
reported drinking alcohol but who did not answer the binge drinking 
question were assigned to a nonresponse category. Binge drinking 
frequency was also evaluated (none, 1–5, and ≥6 binges in past year). 
Binge drinking was not assessed in Nord-Trøndelag; otherwise, miss-
ing data were low (<0.1%) for the majority of parameters, with the 
exception of physical activity (7%) and smoking (5%).
Definition of Outcomes
Gestational hypertension was defined as hypertension diagnosis after 
20 weeks of gestation (systolic BP ≥140 mm Hg or a diastolic BP 
≥90 mm Hg, or both). Preeclampsia diagnosis required the additional 
presence of proteinuria (≥0.3 g in 24 hour urine or ≥1 point increase 
on a urinary dipstick).25 Term and preterm preeclampsia were defined 
based on gestational age at delivery (≥37 or <37 weeks or when 
gestational age was missing (n=287/13 217), having a birth weight 
≥2500 g or <2500 g. Gestational age was determined by ultrasound 
for 80.0%, last menstrual period for 17.8%, and birth weight for 
remaining 2.2% of pregnancies.
Statistical Methods
Descriptive characteristics are reported as mean (SD) and percent. 
Multivariable multinomial logistic regression analyses provided odds 
ratios (OR) and 95% confidence intervals (CI) of characteristics for 
their prediction of gestational hypertension and preeclampsia and in 
a separate analyses of term and preterm preeclampsia. Multivariable 
models included parity (0, 1, or 2+), length of follow-up, baseline age 
(years), daily smoking (yes versus no), pregravid diabetes mellitus, 
and a history of gestational hypertension or preeclampsia in a prior 
pregnancy (obtained via record linkages to pre-CONOR pregnan-
cies), educational level (≤12, 13–16, ≥17 years), marital status (mar-
ried/common law partner versus other), and region of survey (Oslo 
versus other). Mother’s pseudo-ID was entered as a cluster variable. 
When lipids were evaluated, oral contraceptive use was added to the 
multivariable model.
Each potential additional risk factor was evaluated separately with 
the above mentioned parameters. Risk factors evaluated included 
physical activity (≥3 hours per week of light or vigorous activity on 
average in the past year), body mass index classifications (<25, 25–
29.9, and ≥30 kg/m2), oral contraceptive use (yes versus no), alcohol 
consumption frequency (≥1/week, 1–3 times/month, and <1/month 
which included abstainers), binge drinking, a high total cholesterol/
high-density lipoprotein (HDL) cholesterol ratio (≥5 versus lower), 
a high triglyceride level (≥1.7 mmol/L versus lower), and blood 
pressure status (normal: systolic BP <130 mm Hg and diastolic BP 
<85 mm Hg; elevated: systolic BP 130–139 mm Hg or diastolic BP 
85–89 mm Hg; hypertensive: systolic BP ≥140 mm Hg or diastolic 
BP ≥90 mm Hg). Family history of chronic diseases was evaluated in 
unadjusted analyses. Selected postestimation tests were conducted 
to evaluate whether differences in regression coefficients between 
outcome groups were statistically significant. Stata 12 (StataCorp 
LP, College Station, TX) was used in analyses; significance was de-
termined by P<0.05.
Sensitivity Analyses
Three sensitivity analyses were conducted: (1) restricted to those 
with a follow-up <7.2 years (approximately the 70th percentile); (2) 
restricted to nulliparous women; and (3) for preterm preeclampsia, 
restricted to preterm births.
Results
Average age (SD) at the time of the baseline CONOR assess-
ment was 27.9 years (4.5). At baseline, 24.1% patients had 
a higher education, 21.3% were married or had a common 
law partner, and 55.9% engaged in physical activity of ≥3 
hours per week (Table 1). The median follow-up was 4.8 
years (interquartile range 2.6–7.8; maximum 17.5 years). A 
total of 666 (5.0%) pregnancies were affected by either gesta-
tional hypertension (without proteinuria) or preeclampsia, of 
whom 114 were preterm and 315 term preeclampsia. Only 23 
of 237 gestational hypertensive pregnancies resulted in pre-
term deliveries. The percent small-for-gestational age by sex 
(<10th percentile) was 16.5%, 36.8%, and 14.0% for gesta-
tional hypertension, preterm, and term preeclampsia groups, 
respectively, and the percent very small-for-gestational age 
(<2.5th percentile) was 5.9%, 14.9%, and 3.8%, for the 3 
groups, respectively.
A family history of diabetes mellitus and women’s pre-
gravid diabetes mellitus predicted both gestational hyperten-
sion and preeclampsia, whereas a family history of myocardial 
infarction before 60 years of age predicted preeclampsia, but 
not gestational hypertension (postestimation test for differ-
ences in coefficients, P=0.053; Table 2). A family history of 
stroke predicted the combined outcome of gestational hyper-
tension or preeclampsia (OR 1.5; 95% CI: 1.02–2.10), with 
similar but nonsignificant ORs noted for the 2 outcomes sepa-
rately evaluated (Table 2).
Physical activity was protective for preeclampsia (OR 0.8; 
95% CI 0.61–0.97) and particularly for preterm preeclampsia 
(OR 0.5; 95% CI 0.32–0.76), but not for gestational hyper-
tension (Table 3). Body mass index classifications and base-
line hypertensive status predicted both outcomes, albeit with 
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stronger effects noted for gestational hypertension than for 
preeclampsia (postestimation tests, P<0.05). Further, the Oslo 
region had a greater risk of gestational hypertension (OR 1.9; 
95% CI 1.38–2.67) than the other regions, but no regional dif-
ferences in preeclampsia were noted. Baseline educational 
attainment, marital status, smoking, and oral contraceptive 
use were not significantly related to gestational hyperten-
sion or preeclampsia (Table 3). A high total cholesterol/HDL 
cholesterol ratio predicted both gestational hypertension and 
preeclampsia. In contrast, an elevated triglyceride level only 
predicted preeclampsia.
Weekly alcohol consumption relative to none or less than 
once a month was associated with lower risk of preeclampsia 
(OR 0.7; 95% CI 0.48–0.95) and term preeclampsia (OR 0.7; 
95% CI 0.47–0.99; Table 3). In the analyses limited to the 
subcohort with available binge drinking data, weekly alcohol 
consumption (adjusted for binge drinking and other covari-
ates) was associated with an OR for preeclampsia of 0.5 
(95% CI 0.27–0.78) with a stronger protective effect noted 
for preterm preeclampsia (Table 4). Binge drinking (adjusted 
for alcohol consumption frequency and other covariates) was 
associated with increased risk of preeclampsia (OR 1.8; 95% 
CI 1.16–2.92) with an especially strong association noted 
for preterm preeclampsia (OR 3.7; 95% CI 1.25–10.78). 
However, there was no evidence for a binge frequency dose–
response effect given that the OR associated with 1 to 5 
binges was the same as that associated with ≥6 binges in the 
past year (Table 4).
Sensitivity Analyses
The adverse effects of binge drinking for preterm preeclamp-
sia remained significant when analyses were restricted to pre-
term births (n=703; OR 3.2; 95% CI 1.07–9.57), restricted to 
pregnancies occurring within 7.2 years of follow-up (n=9419; 
OR 3.8; 95% CI 1.11–12.81), and when restricted to nullipa-
rous women (n=3975; OR 4.5; 95% CI 1.15–17.30).
In contrast, the protective effect of weekly alcohol con-
sumption was not consistently observed in the sensitivity 
analyses (ie, a protective association was noted when restrict-
ing analyses to within 7.2 years of follow-up, but not when 
restricting analyses to nulliparous women or to preterm 
deliveries).
The protective effect of physical activity for preterm pre-
eclampsia, however, persisted in analyses limited to nullipa-
rous pregnancies (OR 0.5; 95% CI 0.28–0.85); to those with a 
follow-up within 7.2 years (OR 0.5; 95% CI 0.33–0.89); and 
to preterm deliveries (OR 0.5; 95% CI 0.30–0.81). Further, 
the majority of all results reported remained unaltered in the 
sensitivity analyses with the exception that in nulliparous 
pregnancies, a history of oral contraceptive use predicted ges-
tational hypertension (OR 1.9; 95% CI 1.16–3.01).
Discussion
The results presented provide evidence of similarities and 
potentially important differences in predisposing factors for 
gestational hypertension and preeclampsia and preterm pre-
eclampsia. Gestational hypertension and preeclampsia shared 
several baseline risk factors: a family history of diabetes mel-
litus, pregravid diabetes mellitus, baseline blood pressure sta-
tus, obesity, a high total cholesterol/HDL cholesterol ratio, and 
a nonsignificant tendency to have a family history of stroke. 
Preeclampsia, however, was also predicted by a family his-
tory of myocardial infarction before 60 years of age, physical 
inactivity, an elevated triglyceride level, and binge drinking.
The notable adverse association of binge drinking with 
preterm preeclampsia in the current study mirrors the deleteri-
ous cardiovascular disease effects of heavy or binge drinking 
noted in the literature.24,26–28 Biologically plausible mecha-
nisms for the observed association between binge drinking 
and increased risk of preterm preeclampsia, but not gesta-
tional hypertension or term preeclampsia, likely relate to alco-
hol’s impairment of placentation and utero-placental growth 
and function through a variety of mechanisms.29–32
There are only a few studies that report on alcohol con-
sumption’s association with preeclampsia. In the Screening 
for Pregnancy End points study of 5628 participants, early 
pregnancy alcohol consumption including binge drinking was 
not associated with preeclampsia or any other adverse out-
come.33 In a large study of over 1 million singleton birth in 
Missouri, binge drinking was not accessed, but 1 to 2 drinks 
per week was associated with a lower multivariable adjusted 
OR for preeclampsia (OR 0.82; 95% CI, 0.74–0.90).34 Further, 
in an evaluation of blood pressure in pregnancy, those report-
ing light alcohol drinking during pregnancy were reported to 
have significantly lower blood pressure.35 Although our study 
found reduced risk of preeclampsia associated with precon-
ception weekly alcohol consumption, the results were not 
Table 1. Preconception Baseline Demographic and 
Cardiovascular Risk Factors: Cohort Norway and Medical Birth 
Registry of Norway (N=13 217)*
Baseline Characteristics: Mean (SD) or %
Age, y 27.9 (4.5)
Current daily smoking, % 27.1
Education %
  ≤12 y 46.1
  13–16 y 29.8
  ≥17 y 24.1
Married, % 21.3
BMI, kg/m2 23.9 (3.8)
Systolic blood pressure, mm Hg 118.9 (10.9)
Diastolic blood pressure, mm Hg 68.9 (8.4)
Total cholesterol, mmol/L 4.90 (0.92)
HDL cholesterol, mmol/L 1.54 (0.36)
Triglyceride, mmol/L 1.14 (0.68)
Physical activity (≥3 h/wk in past year), % 55.9
Weekly past-year alcohol consumption, % 22.2
Binge drinkers (≥5 drinks/d at least once in past 
year), %†
63.6
BMI indicates body mass index; and HDL, high-density-lipoprotein.
*A total of 8321 women with an average of 1.59 births per woman.
†Excluding Nord-Trøndelag because of lack of inclusion of this question in 
that region.
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consistent in our sensitivity analyses. In contrast, our findings 
that preconception past-year binge drinking was associated 
with increased risk of preterm preeclampsia were consistently 
observed in all subsequent sensitivity analyses. We did not, 
however, observe a dose–response effect related to past-year 
binge drinking frequency. We speculate that there may have 
been reluctance to report the frequency of binge drinking in 
the current study or that binge drinking is a marker for other 
risk factors not measured.
The protective association of physical activity with pre-
term preeclampsia may reflect several protective underlying 
mechanisms beyond weight management, such as reduced 
inflammation and oxidative stress and improved endothelial 
function and placental growth and vascular development.36 
The preponderance of evidence suggests physical activity is 
protective of preeclampsia with a few notable exceptions.37
Our lipid results indicate that nonfasting lipid levels are 
useful in predicting preeclampsia and gestational hypertension 
and note that nonfasting lipid levels have been successfully 
used in cardiovascular research.38,39 In the previous prospec-
tive study in Norway, which forms a subset of our current 
study, cholesterol, low-density lipoprotein cholesterol and 
nonHDL cholesterol were positively related to preeclampsia 
but trends associated with serum triglyceride quintiles were 
nonsignificant.21 In Finland, triglycerides were associated with 
increased risk of preeclampsia but not cholesterol, low-density 
lipoprotein cholesterol, or HDL cholesterol.20 Our lipid results 
corroborate the preponderance of existing evidence that ele-
vated triglyceride levels is a risk factor for preeclampsia40 and 
identified that a high total cholesterol/HDL cholesterol ratio 
was a shared risk factor for gestational hypertension and pre-
eclampsia. Nonfasting triglyceride levels reflect exposures to 
atherogenic remnant lipoproteins39 and elevated triglyceride 
levels associate with small, dense low-density lipoprotein 
cholesterol,41,42 which is readily oxidized. Of relevance to pre-
eclampsia is that oxidized low-density lipoprotein inhibits the 
fetal trophoblast invasion of the uterus.43 Thus, further inves-
tigation of the role of derangements in lipid metabolism in 
preeclampsia is warranted.
Obesity was an important risk factor for gestational hyper-
tension and preeclampsia as expected. However, our postesti-
mation test for equality in coefficients identified that obesity 
was a significantly stronger predictor of gestational hyperten-
sion than preeclampsia, highlighting that for preeclampsia, 
there are other factors that increase risk.
Strengths and Weaknesses
Strengths of the current study include the large population-
based cohort with uniformly assessed preconception risk 
factors and complete linkage to the Medical Birth Registry: 
strengths which contribute to the generalizability of the study. 
Further, the national healthcare system in Norway and our 
multivariate adjustment for educational and marital status 
and region are strengths of the study in that they minimize 
the possibility for disparities in the adequacy of prenatal care 
to influence results. Also, self-reported alcohol consump-
tion data were obtained before pregnancy and would, there-
fore, not be influenced by under-reporting associated with 
the stigma of drinking during pregnancy. However, we rec-
ognize that under-reporting of alcohol consumption is also 
Table 2. Odds Ratios (OR) and 95% Confidence Intervals (CI) for Gestational Hypertension and Preeclampsia 
by Family History of Disease and Prepregnancy Diabetes Mellitus: Cohort Norway and Medical Birth Registry of 
Norway (N=13 217)*
N
G. Hypertension† (n=237) Preeclampsia‡ (n=429)
Cases OR (95% CI)§ Cases OR(95% CI)§
Family history in first-degree relatives
  Diabetes mellitus
   No 12 386 209 1.0 389 1.0
   Yes 831 28 2.1 (1.39–3.09) 40 1.6 (1.12–2.25)
  Cerebrovascular stroke
   No 12 666 223 1.0 404 1.0
   Yes 551 14 1.5 (0.85–2.55) 25 1.5 (0.95–2.24)
  Myocardial infarction before 60 y
   No 12 099 216 1.0 370 1.0
   Yes 1118 21 1.1 (0.69–1.70) 59 1.8 (1.31–2.39)║
  Women’s prepregnancy diabetes mellitus¶
   No 13 138 233 1.0 422 1.0
   Yes 79 4 3.2 (1.14–8.68) 7 3.1 (1.43–6.49)
*A total of 8321 women with an average of 1.59 births per woman.
†Gestational hypertension without proteinuria.
‡Gestational hypertension with proteinuria.
§Multinomial logistic regression model in which mother was entered as a cluster variable.
║P<0.10, postestimation test for differences in coefficients between gestational hypertension and preeclampsia.
¶Identified in the Norwegian Medical Birth Registry (type 1, type 2, or unspecified) and identified in the Cohort Norway baseline assessment.
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Table 3. Preconception Risk Factors for Gestational Hypertension and Preeclampsia: Cohort Norway and Medical Birth Registry of 
Norway (N=13 217)*
N
G. Hypertension† (n=237) Preeclampsia‡ (n=429) Preterm Preeclampsia§ (n=114) Term Preeclampsia║ (n=315)
Cases OR (95% CI)¶ Cases OR (95% CI)¶ Cases OR (95% CI)¶ Cases OR (95% CI)¶
Physical activity (past year)
  Not active 5425 92 1.0 190 1.0 62 1.0 128 1.0
  Active (≥3 h/wk) 6869 131 1.1 (0.8–1.40) 209 0.8 (0.61–0.97) 45 0.5 (0.32–0.76)# 164 0.9 (0.70–1.19)
BMI classifications, kg/m2
  <25 9266 120 1.0 248 1.0 71 1.0 177 1.0
  25–29.9 3037 69 1.8 (1.31–2.56) 127 1.7 (1.32–2.18) 25 1.2 (0.69–1.92) 102 1.9 (1.46–2.52)
  ≥30 869 46 4.2 (2.86–6.21) 50 2.0 (1.35–3.02)** 16 2.2 (1.13–4.09) 34 2.0 (1.21–3.14)
Education
  ≤12 y 6019 105 1.0 189 1.0 51 1.0 138 1.0
  13–16 y 3882 56 0.7 (0.47–0.99) 128 0.9 (0.66–1.14) 30 0.7 (0.43–1.24) 98 0.9 (0.68–1.24)
  ≥17 y 3149 72 0.9 (0.66–1.42) 102 0.8 (0.56–1.09) 29 0.8 (0.45–1.39) 73 0.8 (0.53–1.14)
Smoking daily
  No 9194 173 1.0 305 1.0 80 1.0 225 1.0
  Yes 3415 50 0.8 (0.56–1.08) 95 0.8 (0.56–1.08) 29 0.8 (0.46–1.27) 66 0.8 (0.58–1.02)
Marital status
  Single, divorced 10 348 181 1.0 352 1.0 88 1.0 264 1.0
  Married 2799 56 1.3 (0.90–1.95) 74 1.0 (0.70–1.32) 24 1.0 (0.59–1.68) 50 1.0 (0.67–1.38)
Region
  Other 10 023 148 1.0 311 1.0 78 1.0 233 1.0
  Oslo 3194 89 1.9 (1.38–2.67) 118 1.1 (0.80–1.38) 36 1.3 (0.81 – 2.13) 82 1.0 (0.70 – 1.33)
Blood pressure status††
  Normotensive 10 977 140 1.0 287 1.0 78 1.0 209 1.0
  Elevated 1577 50 2.7 (1.90–3.90) 87 2.1 (1.57–2.87) 19 1.6 (0.91–2.93) 68 2.3 (1.66–3.23)
  Hypertensive 615 46 7.1 (4.84–10.44) 54 3.5 (2.48–4.97)# 17 3.8 (2.04–7.08) 37 3.4 (2.32–5.01)#
Triglyceride**
  <1.7 mmol/L 9014 172 1.0 263 1.0 72 1.0 191 1.0
  ≥1.7 mmol/L 1388 33 1.3 (0.84–2.03) 86 2.4 (1.71–3.30) 22 2.3 (1.29–4.07) 64 2.4 (1.65–3.52)
Chol/HDL ratio**
  <5.0 12 417 214 1.0 382 1.0 97 1.0 285 1.0
  ≥5.0 769 23 1.9 (1.11–3.10) 44 1.8 (1.17–2.84) 15 2.4 (1.24–4.65) 29 1.6 (0.94–2.85)
Oral contraceptive use
  No 7610 137 1.0 250 1.0 63 1.0 187 1.0
  Yes 4061 73 1.1 (0.77–1.45) 136 1.0 (0.75–1.26) 35 1.1 (0.71–1.81) 101 0.9 (0.69 – 1.25)
Alcohol frequency
  Less than monthly 3306 59 1.0 110 1.0 27 1.0 83 1.0
  Occasional 6800 120 1.0 (0.68–1.36) 230 0.9 (0.70–1.17) 67 1.2 (0.73–1.90) 163 0.8 (0.61–1.10)
  Weekly 2880 55 0.9 (0.48–1.39) 85 0.7 (0.48–0.95) 18 0.7 (0.32–1.36) 67 0.7 (0.47–0.99)
BMI indicates body mass index; CI, confidence interval; Chol, cholesterol; and HDL, high-density-lipoprotein.
*A total of 8321 women with an average of 1.59 births per woman.
†Gestational hypertension without proteinuria.
‡Gestational hypertension with proteinuria.
§Delivery <37-wk gestation or when missing gestational age (n=287), with a birth weight <2500 g.
║Delivery 37-wk gestation or later or when missing gestational age (n=287), with birth weight ≥2500 g.
¶Multinomial logistic regression model included covariates: baseline age (years), daily smoking (yes vs no), parity (0, 1, ≥2), pregravid diabetes mellitus, pre-CONOR history of gestational 
hypertension or preeclampsia, marital status (married/common law partner vs other), region of survey (Oslo vs other), education (≤12, 13–16, ≥17 y), and time between CONOR and delivery 
(months); mother was entered as a cluster variable.
#P<0.05, postestimation test for differences in coefficients between the designated category and gestational hypertension.
**Also adjusted for oral contraceptive use.
††Baseline blood pressure status was categorized as normal (systolic BP <130 mm Hg and diastolic BP <85 mm Hg), elevated (systolic BP 130–139 mm Hg or diastolic BP 85–89 mm Hg), 
or hypertensive (systolic BP ≥140 or diastolic BP ≥90 mm Hg).
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possible in nonpregnant study populations. Limitations of 
the study include the lack of information of fasting glucose 
or HbA1C, apolipoproteins, urine samples, and family history 
of hypertension. Other limitations include the largely ethnic 
Norwegian study population and inability to generalize to 
more ethnically diverse populations. Further, changes in risk 
factors over time could not be assessed. In our study, smok-
ing had a nonsignificant association with a lower risk of pre-
eclampsia in multivariable analyses, with the observed OR of 
0.8 being greater than the anticipated OR of 0.5.44 However, 
because of the sharp decline in smoking in women in Norway 
over the past decade, the attenuated smoking association may 
result from misclassification, where smokers identified in 
CONOR would be less likely to be smokers at the time of 
their subsequent pregnancy.
Perspectives
The study suggests similarities and some potentially important 
differences between risk factors for gestational hypertension 
and preeclampsia and between preterm and term preeclamp-
sia. The results are intriguing given the lifetime increased risk 
of cardiovascular morbidity and mortality observed in women 
with a history of preeclampsia.4–8 Further, although the major-
ity of prospective studies of long-term consequences have 
focused on preeclampsia, an 18-year follow-up of mothers 
found that women with a history of gestational hypertension 
had similar predicted 10-year cardiovascular disease risk 
based on the Framingham score as women with a history of 
preeclampsia.45 Our findings support the hypotheses that preg-
nancy unmasks predisposing familial and modifiable cardio-
metabolic risk. However, in the current study, a greater number 
of risk factors predicted preeclampsia than gestational hyper-
tension. The presence of risk factors in women of reproductive 
age could help clinicians identify women needing greater clin-
ical monitoring and lifestyle changes. Promoting better life-
styles in women of reproductive age would be advantageous 
for preventing the short- and long-term outcomes associated 
with hypertension disorders of pregnancy.
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What Is New?
•	Preeclampsia, but not gestational hypertension, was predicted by a fam-
ily history of myocardial infarction before 60 years of age, binge drinking, 
physical inactivity, and an elevated triglyceride level.
•	Gestational hypertension and preeclampsia shared many pregravid risk 
factors, including a high total cholesterol/high-density lipoprotein cho-
lesterol ratio, family history of diabetes mellitus, pregravid diabetes mel-
litus, overweight and obesity, and baseline blood pressure status.
What Is Relevant?
•	The majority of risk factors were modifiable.
Summary
Physical activity, avoidance of binge drinking, weight management, 
blood pressure, and glucose monitoring and control for women of 
reproductive age may reduce hypertensive disorders of pregnancy 
and its short- and long-term sequelae.
Novelty and Significance
 at Universitet I Bergen on June 23, 2016http://hyper.ahajournals.org/Downloaded from 
Skjærven
Grace M. Egeland, Kari Klungsøyr, Nina Øyen, Grethe S. Tell, Øyvind Næss and Rolv
and Preeclampsia: Cohort Norway Study
Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension
Print ISSN: 0194-911X. Online ISSN: 1524-4563 
Copyright © 2016 American Heart Association, Inc. All rights reserved.
is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231Hypertension 
doi: 10.1161/HYPERTENSIONAHA.116.07099
2016;67:1173-1180; originally published online April 25, 2016;Hypertension. 
Free via Open Access 
 http://hyper.ahajournals.org/content/67/6/1173
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 http://hyper.ahajournals.org/content/suppl/2016/04/24/HYPERTENSIONAHA.116.07099.DC1.html
Data Supplement (unedited) at:
  
 http://hyper.ahajournals.org//subscriptions/
is online at: Hypertension  Information about subscribing to Subscriptions:
  
 http://www.lww.com/reprints
 Information about reprints can be found online at: Reprints:
  
document. Permissions and Rights Question and Answer this process is available in the
click Request Permissions in the middle column of the Web page under Services. Further information about
Office. Once the online version of the published article for which permission is being requested is located, 
 can be obtained via RightsLink, a service of the Copyright Clearance Center, not the EditorialHypertensionin
 Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:







Preconception cardiovascular risk factor differences between gestational hypertension 




Grace M. Egeland PhD.a,b, Kari Klungsøyr MD PhD.a,b, Nina Øyen MD PhDa 
Grethe S. Tell PhDa,b, Øyvind Næss MD PhDb,c , Rolv Skjærven PhDa,c 
 
aDepartment of Global Public Health and Primary Care, University of Bergen, Norway 
bDivision of Epidemiology, Norwegian Institute of Public Health, Norway. 







G.M. Egeland PhD, Norwegian Institute of Public Health, Kalfarveien 31, Bergen, Norway, 






Materials and Methods 
 
Linkages 
Women provided written informed consent and Regional Ethics Committees approved the 
health surveys and record linkages (REK 2010/260, REK Southeast). The Medical Birth 
Registry involves compulsory recording of medical characteristics of births of gestational age 
16 weeks or greater.1   Linkages between the health surveys participating in Cohort Norway 
(CONOR) and the Medical Birth Registry of Norway enabled review of births prior to 
CONOR participation for determining the presence of a history of either gestational 
hypertension or preeclampsia prior to CONOR participation. Further, the linkages to births 
after CONOR participation enabled the prospective evaluation of CONOR risk factors as 
predictors of subsequent gestational hypertension or preeclampsia. 
 
Exclusions  
Exclusions included preexisting hypertension (antihypertensive medications reported in 
CONOR, n=275; or pregravid hypertension noted in the Medical Birth Registry, n=133); 
nonviable births (i.e., gestational age < 22 weeks, n=65, or a birth weight < 500 g if 
gestational age was missing, n=7);2  mother pregnant during or delivered less than one year 
prior to CONOR participation (n=3,100); and multiple birth pregnancies (n=661). With minor 
overlap, a total of 4,103 were excluded, resulting in 13,217 singleton births for analyses 
(representing 8,321 women and 1.59 births/woman) (Figure S1).  
 
Preexisting history of gestational hypertension or preeclampsia 
Of 13,217 singleton births, 4,764 (36%) had a sibling born prior to mother’s CONOR 
participation; 5.8 % had either gestational hypertension or preeclampsia noted in the Medical 
Birth Registry prior to CONOR participation. 
 
Determination of Preterm and Term Deliveries 
Some misclassification of term and preterm deliveries always exists. Of the 287 pregnancies 
where gestational age was missing, 14 were preterm based on their birthweight (11 preterm of 
275 normotensive pregnancies, and 3 preterm preeclampsia pregnancies). Further, the extent 
of misclassification of term and preterm deliveries was evaluated in a subset of the study 
population which had both ultrasound and last menstrual period date available and was found 
to be negligible.   
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 Figure S1.  Flow diagram of participants in the current study. 
 
17,320 Births in Medical Birth Registry of Norway (1995-2012) 
where mother previously participated in  
Cohort of Norway (CONOR) 
 (1994-2003) 
Exclusions:   
Multiple birth pregnancies, preexisting hypertension,  
non-viable birth (< 22 weeks or <500 g), mother pregnant during participation 
 in CONOR or delivered < 1 year prior to CONOR participation. 
4,103 births excluded 
13,217 Singleton Births 
8,321 women (1.59 births/woman) 
With CONOR baseline assessment of risk factors 
Binge drinking sub-study: 
 
Excluded Nord-Trøndelag (6,729 births) which did not assess binge drinking. 
 
Resulted in 6,488 births to 4,349 women (1.49 births/woman) for analyses. 
  
